ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine

Author:

Döhner Hartmut1,Pratz Keith W.2,DiNardo Courtney D.3,Jonas Brian A.4,Pullarkat Vinod A.5,Thirman Michael J.6,Recher Christian7,Schuh Andre C.8,Babu Sunil9,Dail Monique10,Ku Grace10,Sun Yan11,Potluri Jalaja11,Chyla Brenda11,Pollyea Daniel A.12

Affiliation:

1. 1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

2. 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

3. 3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

4. 4Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA

5. 5Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

6. 6Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

7. 7Service d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

8. 8Princess Margaret Cancer Centre, Toronto, Canada

9. 9Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN

10. 10Genentech Inc., South San Francisco, CA

11. 11AbbVie Inc., North Chicago, IL

12. 12Division of Hematology, University of Colorado School of Medicine, Aurora, CO

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3